Johns Hopkins promoted self-spreading vaccines in 2018 and Pfizer mentioned potential risks during COVID vaccine trials
Documents from Pfizer, Johns Hopkins and others discuss the potential for COVID-19 vaccines to “self-spread” to non-vaccinated individuals coming in contact with a recently vaccinated person.
Watch Infowars’ latest special report on vaccine shedding below:
In fact, a 2018 report by Johns Hopkins Bloomberg School of Public Health’s Center for Health Security floated the idea of using this type of vaccine to intentionally spread to others for “protection” against disease.
Under the section, “Self-Spreading Vaccines,” the Johns Hopkins document states, “Selfspreading vaccines are genetically engineered to move through populations like communicable diseases, but rather than causing disease, they confer protection. The vision is that a small number of individuals in a target population could be vaccinated, and the vaccine strain would then circulate in the population much like a pathogenic virus, resulting in rapid, widespread immunity.”
The paper admits self-spreading vaccines being implemented would come with challenges, such as “informed consent” and potentially life-threatening contraindications.
“The ethical and regulatory challenges surrounding informed consent and prevention and monitoring of adverse events would be critical challenges to implementing this approach even in an extreme event,” the document states.
The Johns Hopkins report also noted, “There is a not insignificant risk of the vaccine virus reverting to wild-type virulence, as has sometimes occurred with the oral polio vaccine.”
A Pfizer placebo-controlled COVID-19 vaccine safety study similarly describes the potential for the shot to cause adverse effects in people in close contact with recently vaccinated individuals.
However, in the Pfizer study self-spreading is discussed as an unintentional possibility that could cause harm.
Under the section “Occupational Exposure,” the Pfizer study explains, “An occupational exposure occurs when a person receives unplanned direct contact with the study intervention, which may or may not lead to the occurrence of an AE. Such persons may include healthcare providers, family members, and other roles that are involved in the trial participant’s care.”
The “study intervention” being referred to is a person who recently received the Pfizer COVID-19 vaccine as part of the study, and an “AE” is an adverse event or bad reaction.
The document warns under a section called “Exposure During Pregnancy” that if “A female family member or healthcare provider reports that she is pregnant after having been exposed to the study intervention by inhalation or skin contact,” the exposure should be reported within 24 hours.
Another way someone could be exposed is if “A male participant who is receiving or has discontinued study intervention exposes a female partner prior to or around the time of conception.”
Pfizer even described a scenario where “A male family member or healthcare provider who has been exposed to the study intervention by inhalation or skin contact then exposes his female partner prior to
or around the time of conception.”